StockDuty ← Dashboard Aug 24, 2026 09:34 PM ET
CatalystFDA/Bio

BAUSCH + LOMB MOVING DUAL-ACTION DRY EYE DROPS INTO PHASE 3 - SEEKINGALPHA

Phase 3 initiation signals pivotal trial catalyst for dual-action dry eye candidate.

What changed
Why it matters
Phase 3 initiation signals pivotal trial catalyst for dual-action dry eye candidate.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →